A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL

Clinical trial NCT03018093 · UNKNOWN

Trial details

NCT number

NCT03018093

Sponsor

Shanghai AbelZeta Ltd.

Status

UNKNOWN

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-01-01

Primary completion

2018-08-01

Enrollment

20

View on ClinicalTrials.gov